OptimizeRx Corporation logo OPRX - OptimizeRx Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 11
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $10.50 DETAILS
HIGH: $14.00
LOW: $7.00
MEDIAN: $10.50
CONSENSUS: $10.50
UPSIDE: 112.55%

About OptimizeRx Corporation (https://www.optimizerx.com)

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

Key Executives

NAME TITLE DOB SALARY
Stephen L. Silvestro Chief Executive Officer & Director 1978 $1,131,223 USD
Edward Stelmakh Chief Financial & Strategic Officer 1966 $937,673 USD
Theresa Greco Chief Commercial Officer 1973 $781,771 USD
Marion Odence-Ford Chief Legal & Administrative Officer 1965 $428,117 USD
Andrew Jacob D'Silva Chief Business Officer 1986
Brendan Merrell Chief Operating Officer 1985
Doug Besch Chief Product Officer & Chief Technology Officer 1982
Heather Favazza Controller
Maira Alejandra Media Relations Manager
Sheryl Kearney Human Resources Manager

Company Peers

Peer analysis pending, check back in 1-2 minutes.